edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
SynAct Pharma has reported that some early preclinical data have shown that resomelagon may reduce inflammation and joint damage associated with osteoarthritis, and, hence, may reduce pain and improve quality of life for this patient population. While the current focus is in rheumatoid arthritis, these latest findings support the exploration of the drug candidate in this new indication. Further data are due to be presented at the 17th World Congress of Inflammation, to be held in Brazil, 8–12 September 2026.
Healthcare | Comment
Healthcare | Comment
Industrials | Comment
Industrials | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.